Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules
- PMID: 32765441
- PMCID: PMC7378892
- DOI: 10.3389/fmicb.2020.01511
Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules
Abstract
Human cytomegalovirus (HCMV), a ubiquitous beta-herpesvirus, is able to establish lifelong latency after initial infection. Periodical reactivation occurs after immunosuppression, remaining a major cause of death in immunocompromised patients. HCMV has to reach a structural and functional balance with the host at its earliest entry. Virion-carried mediators are considered to play pivotal roles in viral adaptation into a new cellular environment upon entry. Additionally, one clear difference between primary infection and reactivation is the idea that virion-packaged factors are already formed such that those molecules can be used swiftly by the virus. In contrast, virion-carried mediators have to be transcribed and translated; thus, they are not readily available during reactivation. Hence, understanding virion-carried molecules helps to elucidate HCMV reactivation. In this article, the impact of virion-packaged molecules on viral structure, biological behavior, and viral life cycle will be reviewed.
Keywords: HCMV; envelope; primary infection; reactivation; tegument; virion-carried molecules.
Copyright © 2020 Wang and Zhao.
Figures
References
-
- Ahn J. H., Jang W. J., Hayward G. S. (1999). The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10). J. Virol. 73 10458–10471. 10.1128/jvi.73.12.10458-10471.1999 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
